Most Democratic-led states plan to keep recommending the hepatitis B vaccine for newborns. This stance opposes new federal guidance from a panel selected by Health and Human Services Secretary Robert F. Kennedy Jr. The decision highlights ongoing tensions over vaccine policies.
A federal vaccine advisory panel, appointed by Health and Human Services Secretary Robert F. Kennedy Jr., voted last week to advise against the routine administration of the hepatitis B vaccine at birth. This recommendation marks a shift in longstanding public health practices aimed at preventing the infectious disease, which can lead to serious liver conditions.
Despite this guidance from the Centers for Disease Control and Prevention (CDC) panel, most states led by Democratic governors have announced they will continue to universally recommend and provide the vaccine to newborns. Officials in these states emphasize the vaccine's proven effectiveness in curbing hepatitis B transmission, particularly from mother to child during delivery.
The panel's vote reflects broader policy directions under Kennedy's leadership, focusing on reevaluating vaccine schedules. However, state health departments argue that local data and expert consensus support maintaining the birth dose. No specific timeline for implementation of the federal advice has been set, leaving room for varied approaches across the country.
This development underscores the balance between federal recommendations and state autonomy in public health matters. As of now, the majority of Democratic-led states remain committed to the existing protocol, prioritizing early protection against the virus.
